News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
341,212 Results
Type
Article (18196)
Company Profile (71)
Press Release (322945)
Multimedia
Podcasts (26)
Webinars (6)
Section
Business (95152)
Career Advice (1376)
Deals (18293)
Drug Delivery (43)
Drug Development (53592)
Employer Resources (65)
FDA (8730)
Job Trends (7410)
News (174395)
Policy (15032)
Tag
Academia (1295)
Accelerated approval (4)
Adcomms (11)
Allergies (65)
Alliances (19823)
ALS (65)
Alzheimer's disease (764)
Antibody-drug conjugate (ADC) (108)
Approvals (8790)
Artificial intelligence (172)
Autoimmune disease (20)
Automation (10)
Bankruptcy (140)
Best Places to Work (6348)
BIOSECURE Act (6)
Biosimilars (72)
Biotechnology (54)
Bladder cancer (70)
Brain cancer (26)
Breast cancer (255)
Cancer (1843)
Cardiovascular disease (129)
Career advice (1074)
Career pathing (12)
CAR-T (93)
Cell therapy (289)
Cervical cancer (16)
Clinical research (45348)
Collaboration (581)
Company closure (1)
Compensation (393)
Complete response letters (10)
COVID-19 (2191)
CRISPR (29)
C-suite (145)
Cystic fibrosis (54)
Data (1891)
Denatured (4)
Depression (28)
Diabetes (193)
Diagnostics (3631)
Digital health (14)
Diversity (1)
Diversity, equity & inclusion (12)
Drug discovery (81)
Drug pricing (31)
Drug shortages (10)
Duchenne muscular dystrophy (74)
Earnings (53539)
Editorial (17)
Employer branding (8)
Employer resources (55)
Events (54429)
Executive appointments (464)
FDA (9769)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (508)
Gene editing (69)
Generative AI (10)
Gene therapy (213)
GLP-1 (468)
Government (2190)
Grass and pollen (5)
Guidances (146)
Healthcare (9431)
Huntington's disease (17)
IgA nephropathy (23)
Immunology and inflammation (89)
Indications (24)
Infectious disease (2293)
Inflammatory bowel disease (87)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (62)
Interviews (253)
IPO (10526)
IRA (15)
Job creations (1431)
Job search strategy (944)
Kidney cancer (11)
Labor market (26)
Layoffs (241)
Leadership (12)
Legal (2675)
Liver cancer (55)
Lung cancer (263)
Lymphoma (136)
Machine learning (7)
Management (21)
Manufacturing (170)
MASH (66)
Medical device (6640)
Medtech (6640)
Mergers & acquisitions (8240)
Metabolic disorders (477)
Multiple sclerosis (67)
NASH (17)
Neurodegenerative disease (69)
Neuropsychiatric disorders (20)
Neuroscience (1157)
NextGen: Class of 2025 (2741)
Non-profit (2277)
Now hiring (8)
Obesity (223)
Opinion (109)
Ovarian cancer (64)
Pain (76)
Pancreatic cancer (77)
Parkinson's disease (104)
Partnered (8)
Patents (137)
Patient recruitment (80)
Peanut (33)
People (19859)
Pharmaceutical (18)
Pharmacy benefit managers (4)
Phase I (12029)
Phase II (18954)
Phase III (18546)
Pipeline (1211)
Policy (55)
Postmarket research (1426)
Preclinical (4405)
Press Release (20)
Prostate cancer (88)
Psychedelics (14)
Radiopharmaceuticals (133)
Rare diseases (261)
Real estate (1983)
Recruiting (26)
Regulatory (11560)
Reports (30)
Research institute (1175)
Resumes & cover letters (260)
Rett syndrome (5)
RNA editing (2)
RSV (34)
Schizophrenia (61)
Series A (85)
Series B (58)
Service/supplier (8)
Sickle cell disease (39)
Special edition (17)
Spinal muscular atrophy (108)
Sponsored (15)
Startups (1506)
Stomach cancer (6)
Supply chain (47)
Tariffs (20)
The Weekly (22)
Vaccines (526)
Venture capitalists (26)
Weight loss (128)
Women's health (20)
Worklife (11)
Date
Today (89)
Last 7 days (767)
Last 30 days (2318)
Last 365 days (22897)
2025 (8849)
2024 (22763)
2023 (24263)
2022 (30419)
2021 (32443)
2020 (30717)
2019 (22465)
2018 (16988)
2017 (17766)
2016 (15579)
2015 (18275)
2014 (13409)
2013 (10256)
2012 (10942)
2011 (11481)
2010 (9882)
Location
Africa (416)
Alabama (25)
Alaska (3)
Arizona (61)
Arkansas (8)
Asia (22943)
Australia (4179)
California (4761)
Canada (1345)
China (387)
Colorado (207)
Connecticut (217)
Delaware (133)
Europe (49417)
Florida (569)
Georgia (137)
Idaho (22)
Illinois (341)
India (17)
Indiana (206)
Iowa (6)
Japan (150)
Kansas (65)
Kentucky (6)
Louisiana (7)
Maine (36)
Maryland (509)
Massachusetts (3315)
Michigan (90)
Minnesota (248)
Mississippi (2)
Missouri (56)
Montana (12)
Nebraska (7)
Nevada (49)
New Hampshire (35)
New Jersey (1292)
New Mexico (8)
New York (1222)
North Carolina (636)
North Dakota (4)
Northern California (2132)
Ohio (142)
Oklahoma (5)
Oregon (20)
Pennsylvania (899)
Puerto Rico (6)
Rhode Island (15)
South America (648)
South Carolina (10)
Southern California (1813)
Tennessee (59)
Texas (666)
United States (16299)
Utah (104)
Virginia (104)
Washington D.C. (34)
Washington State (399)
West Virginia (1)
Wisconsin (54)
341,212 Results for "3 v biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Fluent BioSciences Debuts PIPseq™ V with Unique Molecular Counting Strategy
Fluent BioSciences, a leader in single-cell technology innovation, is proud to herald the launch of our latest product line, the PIPseq V 3' Single Cell RNA Sequencing Kits.
May 29, 2024
·
1 min read
Press Releases
Nordic Bioscience announces PRO-C3 launched by Roche Diagnostics on cobas analysers
May 8, 2025
·
2 min read
Press Releases
Alligator Bioscience Completes Phase 3 GMP Manufacturing of Mitazalimab, Remains on Track for Trial Initiation with Partner
May 9, 2025
·
1 min read
Press Releases
Neurocrine Biosciences Initiates Phase 3 Registrational Program for NBI-1117568 as Potential Treatment for Adults with Schizophrenia
April 30, 2025
·
7 min read
Press Releases
Featured Talk at SID 2025: Prof. Maria Hordinsky and Alpenglow Biosciences Present Innovations in 3D Imaging for Alopecia and Skin Disease
April 30, 2025
·
2 min read
Press Releases
AACR 2025: Crown Bioscience Unveils 3D Bone Marrow Niche In Vitro Models for Oncology Preclinical Screening in Hematological Malignancies
April 29, 2025
·
4 min read
Press Releases
Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
April 30, 2025
·
3 min read
Press Releases
Alpenglow Biosciences Announces AACR 2025 Dinner Lecture: “Decoding Endometrial Cancers: A Spatial Biology Odyssey in 2D and 3D”
April 8, 2025
·
2 min read
Press Releases
Nielsen BioSciences Successfully Completes Enrollment into Phase 3 Trial of CANDIN for the Treatment of Common Warts
February 26, 2025
·
3 min read
Press Releases
Ventyx Biosciences Expands SAB with Renowned NLRP3 Experts and Prominent Neurodegenerative and Cardiometabolic Disease Specialists
April 1, 2025
·
8 min read
1 of 34,122
Next
